SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000920465-19-000051
Filing Date
2019-03-13
Accepted
2019-03-13 20:54:52
Documents
1
Period of Report
2019-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_155252487518774.html 3  
1 FORM 3 wf-form3_155252487518774.xml 3 3012
  Complete submission text file 0000920465-19-000051.txt   4361
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address
Wellinghoff Darryl (Reporting) CIK: 0001770350 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36282 | Film No.: 19679582